On Oct. 1, the U.S. Patent and Trademark Office issued two trademarks to Scott Hemingway’s client, Omega Alpha Pharmaceuticals. But to obtain them, Hemingway had to do battle before the Trademark Trial and Appeal Board over whether his client’s use of the Greek letters in its name was “deceptive.”
The background to the TTAB’s March 26 decision in In Re Omega Alpha Pharmaceuticals Inc. is as follows. Omega Alpha filed an application with the U.S. Patent and Trademark office to register the Greek letters in its name for a variety of nutritional/herbal supplements.